Prof Taylor opened the meeting and briefly highlighted the epidemiology of pregnancy in women with chronic rheumatic diseases (CRD). Dr Moltó presented the importance of disease control in women of childbearing age and various factors influencing fertility. Prof Nelson-Piercy addressed the need for a patient-centred multidisciplinary approach at each stage of pregnancy and how new clinical data may further inform current recommendations on the treatment of women with CRD. Dr Clowse concluded the meeting by reviewing the postpartum treatment recommendations for managing disease flares in this patient population.

Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend, Prof Boehncke shared the evidence on fumarates in general and oral dimethyl fumarate (DMF) in particular. Dr Weisenseel closed the symposium by discussing the use of fumarates in current clinical practice.